Urinary Incontinence (UI) is a prevalent condition impacting women across all age groups, varing in both severity and type. Urinary Incontinence affects 25%-45% of women worldwide. A systematic review explains that menopause-driven estrogen decline leads to atrophy of pelvic floor muscles (PFM). The goal of this randomized controlled trial is to compare the effects of telerehabilitation-based pelvic floor muscle training with a supervised face-to-face pelvic floor muscle training program in improving urinary incontinence symptoms, pelvic floor muscle funtion and quality of life (QoL) in postmenopausal women. Participnts will be randomly assigned to one of the two groups, and both will receive an identical standardized pelvic floor muscle training protocol. The results of this clinical trial will help evaluate how telerehabilitation can provide support for postmenopausal women with urinary incontinence and improve health outcomes.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) score
Timeframe: Baseline and 6 weeks
Change in pelvic floor muscle strength using the Modified Oxford Scale
Timeframe: Baseline and 6 weeks
Change in Urinary Impact Questionnaire short form (UIQ-7) score
Timeframe: Baseline and 6 weeks
Change in Incontinence Impact Questionnaire, Short Form (IIQ-7) score
Timeframe: Baseline and 6 weeks